Alamar Biosciences Funding: $250M Raised, Series C
Alamar Biosciences is a Biotech company based in Fremont, California. It has raised $250M in total funding. Latest round: Series C. Backed by Sands Capital.
Alamar Biosciences funding overview
Alamar Biosciences is a Biotech company based in Fremont, California. Alamar Biosciences has raised $250M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C. Investors on record include Sands Capital.
Alamar Biosciences at a glance
Total raised
$250M
Latest round
Series C
Industry
Biotech
Headquarters
Fremont, California
Notable investors
Sands Capital
Frequently asked about Alamar Biosciences funding
How much has Alamar Biosciences raised?
Alamar Biosciences has raised $250M in total disclosed funding across the rounds on record.
Who has invested in Alamar Biosciences?
Sands Capital are named among the investors backing Alamar Biosciences.
What was the latest Alamar Biosciences funding round?
The most recent disclosed round is a Series C.
Where is Alamar Biosciences based?
Alamar Biosciences is based in Fremont, California.
What sector does Alamar Biosciences operate in?
Alamar Biosciences is tracked under Biotech from Fremont, California, with $250M in disclosed funding.
Totals shown for Alamar Biosciences aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Fremont and the investors behind them below.
